`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`PFIZER, INC., and
`SAMSUNG BIOEPIS CO., LTD.,
`Petitioners,
`
`v.
`
`GENENTECH, INC.,
`Patent Owner.
`____________
`
`Case IPR2017-014891
`Patent 6,407,213
`____________
`
`
`PETITIONER PFIZER’S OBJECTIONS TO ADMISSIBILITY OF
`EVIDENCE
`
`
`
`
`
`
`1 Case IPR2017-02140 has been joined with this proceeding.
`
`
`
`Petitioner Pfizer’s Objections to Admissibility of Evidence for IPR2017-01489
`
`Pursuant to 37 C.F.R. § 42.64(b)(1), Petitioner objects to the admissibility of
`
`evidence as follows:
`
`Exhibit(s)
`2041
`
`Objections2
`FRE 602: The declarant lacks sufficient personal
`
`knowledge to testify on the asserted subject matter. See,
`
`e.g., ¶¶ 45, 47, 57, 60, 64–87, 89–95, 98–100, 102, 111, 112,
`
`116, 122, 126, 127, 133, 135–38, 141, 144, 147, 149, 152,
`
`157, 160, 162, 163, 165–68, 171–85, 187–92, 194–97, 199–
`
`208, 210–14, 216–224, 226–38, 240–48, 250, 251, 253, 254,
`
`256–59, 261–68.
`
`FRE 702: The declarant is not qualified as an expert on the
`
`subject matter of his declaration, and thus cannot testify in
`
`the form of an opinion or otherwise in a manner that would
`
`assist the Board. The testimony is based on insufficient facts
`
`or data, the product of unreliable principles or methods,
`
`and/or an unreliable application of the principles or methods
`
`to the facts of this case.
`
`
`2 References to “FRE” are to the Federal Rules of Evidence.
`
`
`
`2
`
`
`
`Petitioner Pfizer’s Objections to Admissibility of Evidence for IPR2017-01489
`
`Exhibit(s)
`
`Objections2
`FRE 703: Patent Owner has not established that an expert in
`
`the particular field would reasonably rely on the kinds of
`
`facts or data relied upon in forming an opinion on the
`
`subject. The probative value of the testimony is substantially
`
`outweighed by the danger of unfair prejudice.
`
`FRE 705/37 C.F.R. § 42.65: The testimony lacks a
`
`disclosed basis of sufficient facts or data.
`
`FRE 801/802: The testimony relies on hearsay if offered to
`
`prove the truth of any matter asserted therein, and does not
`
`fall under any exceptions.
`
`FRE 901/902: The testimony relies on improper exhibits for
`
`which Patent Owner has not produced evidence sufficient to
`
`support a finding that the exhibits are what Patent Owner
`
`claims they are. Nor has Patent Owner presented any
`
`evidence that these exhibits are self-authenticating under
`
`FRE 902. See, e.g., ¶¶ 87, 122, 187.
`
`FRE 1002/1003: The testimony relies on evidence that
`
`Patent Owner has not shown is the original document or an
`
`authentic duplicate. See, e.g., ¶¶ 87, 122, 187.
`
`
`
`3
`
`
`
`Petitioner Pfizer’s Objections to Admissibility of Evidence for IPR2017-01489
`
`Exhibit(s)
`
`Objections2
`Lack of Foundation: The declarant does not provide
`
`sufficient explanation of what the evidence allegedly shows.
`
`2042
`
`FRE 401/402: This document is irrelevant. Patent Owner
`
`has failed to identify any fact of consequence in determining
`
`an issue in this proceeding that is made more or less
`
`probable by this exhibit.
`
`FRE 403: Any probative value of the exhibit is substantially
`
`outweighed by a danger of confusing the issues.
`
`FRE 801/802: The exhibit relies on hearsay if offered to
`
`prove the truth of any matter allegedly asserted therein, and
`
`does not fall under any exceptions.
`
`Lack of Foundation: Patent Owner has not provided
`
`sufficient explanation of what the evidence allegedly shows.
`
`2043
`
`FRE 401/402: This document is irrelevant. Patent Owner
`
`has failed to identify any fact of consequence in determining
`
`an issue in this proceeding that is made more or less
`
`probable by this exhibit.
`
`FRE 403: Any probative value of the exhibit is substantially
`
`outweighed by a danger of confusing the issues.
`
`
`
`4
`
`
`
`Petitioner Pfizer’s Objections to Admissibility of Evidence for IPR2017-01489
`
`Exhibit(s)
`
`Objections2
`FRE 801/802: The exhibit relies on hearsay if offered to
`
`prove the truth of any matter allegedly asserted therein, and
`
`does not fall under any exceptions.
`
`Lack of Foundation: Patent Owner has not provided
`
`sufficient explanation of what the evidence allegedly shows.
`
`2044
`
`FRE 401/402: This document is irrelevant. Patent Owner
`
`has failed to identify any fact of consequence in determining
`
`an issue in this proceeding that is made more or less
`
`probable by this exhibit.
`
`FRE 403: Any probative value of the exhibit is substantially
`
`outweighed by a danger of confusing the issues.
`
`FRE 801/802: The exhibit relies on hearsay if offered to
`
`prove the truth of any matter allegedly asserted therein, and
`
`does not fall under any exceptions.
`
`FRE 901/902: Patent Owner has not produced evidence
`
`sufficient to support a finding that the exhibit is what Patent
`
`Owner claims it is. Nor has Patent Owner presented any
`
`evidence that the exhibit is self-authenticating under FRE
`
`902.
`
`5
`
`
`
`
`
`Petitioner Pfizer’s Objections to Admissibility of Evidence for IPR2017-01489
`
`Exhibit(s)
`
`Objections2
`FRE 1002/1003: Patent Owner has not shown this exhibit is
`
`the original document or an authentic duplicate.
`
`Lack of Foundation: Patent Owner has not provided
`
`sufficient explanation of what the evidence allegedly shows.
`
`2045
`
`FRE 401/402: This document is irrelevant. Patent Owner
`
`has failed to identify any fact of consequence in determining
`
`an issue in this proceeding that is made more or less
`
`probable by this exhibit.
`
`FRE 403: Any probative value of the exhibit is substantially
`
`outweighed by a danger of confusing the issues.
`
`FRE 801/802: The exhibit relies on hearsay if offered to
`
`prove the truth of any matter allegedly asserted therein, and
`
`does not fall under any exceptions.
`
`FRE 901/902: Patent Owner has not produced evidence
`
`sufficient to support a finding that the exhibit is what Patent
`
`Owner claims it is. Nor has Patent Owner presented any
`
`evidence that the exhibit is self-authenticating under FRE
`
`902.
`
`
`
`6
`
`
`
`Petitioner Pfizer’s Objections to Admissibility of Evidence for IPR2017-01489
`
`Exhibit(s)
`
`Objections2
`FRE 1002/1003: Patent Owner has not shown this exhibit is
`
`the original document or an authentic duplicate.
`
`Lack of Foundation: Patent Owner has not provided
`
`sufficient explanation of what the evidence allegedly shows.
`
`2051
`
`FRE 401/402: This document is irrelevant. Patent Owner
`
`has failed to identify any fact of consequence in determining
`
`an issue in this proceeding that is made more or less
`
`probable by this exhibit.
`
`FRE 403: Any probative value of the exhibit is substantially
`
`outweighed by a danger of confusing the issues.
`
`FRE 801/802: The exhibit relies on hearsay if offered to
`
`prove the truth of any matter allegedly asserted therein, and
`
`does not fall under any exceptions.
`
`FRE 901/902: Patent Owner has not produced evidence
`
`sufficient to support a finding that the exhibit is what Patent
`
`Owner claims it is. Nor has Patent Owner presented any
`
`evidence that the exhibit is self-authenticating under FRE
`
`902.
`
`
`
`7
`
`
`
`Petitioner Pfizer’s Objections to Admissibility of Evidence for IPR2017-01489
`
`Exhibit(s)
`
`Objections2
`FRE 1002/1003: Patent Owner has not shown this exhibit is
`
`the original document or an authentic duplicate.
`
`Lack of Foundation: Patent Owner has not provided
`
`sufficient explanation of what the evidence allegedly shows.
`
`2052
`
`FRE 401/402: This document is irrelevant. Patent Owner
`
`has failed to identify any fact of consequence in determining
`
`an issue in this proceeding that is made more or less
`
`probable by this exhibit.
`
`FRE 403: Any probative value of the exhibit is substantially
`
`outweighed by a danger of confusing the issues.
`
`FRE 801/802: The exhibit relies on hearsay if offered to
`
`prove the truth of any matter allegedly asserted therein, and
`
`does not fall under any exceptions.
`
`FRE 901/902: Patent Owner has not produced evidence
`
`sufficient to support a finding that the exhibit is what Patent
`
`Owner claims it is. Nor has Patent Owner presented any
`
`evidence that the exhibit is self-authenticating under FRE
`
`902.
`
`
`
`8
`
`
`
`Petitioner Pfizer’s Objections to Admissibility of Evidence for IPR2017-01489
`
`Exhibit(s)
`
`Objections2
`FRE 1002/1003: Patent Owner has not shown this exhibit is
`
`the original document or an authentic duplicate.
`
`Lack of Foundation: Patent Owner has not provided
`
`sufficient explanation of what the evidence allegedly shows.
`
`2053
`
`FRE 401/402: This document is irrelevant. Patent Owner
`
`has failed to identify any fact of consequence in determining
`
`an issue in this proceeding that is made more or less
`
`probable by this exhibit.
`
`FRE 403: Any probative value of the exhibit is substantially
`
`outweighed by a danger of confusing the issues.
`
`FRE 801/802: The exhibit relies on hearsay if offered to
`
`prove the truth of any matter allegedly asserted therein, and
`
`does not fall under any exceptions.
`
`FRE 901/902: Patent Owner has not produced evidence
`
`sufficient to support a finding that the exhibit is what Patent
`
`Owner claims it is. Nor has Patent Owner presented any
`
`evidence that the exhibit is self-authenticating under FRE
`
`902.
`
`
`
`9
`
`
`
`Petitioner Pfizer’s Objections to Admissibility of Evidence for IPR2017-01489
`
`Exhibit(s)
`
`Objections2
`FRE 1002/1003: Patent Owner has not shown this exhibit is
`
`the original document or an authentic duplicate.
`
`Lack of Foundation: Patent Owner has not provided
`
`sufficient explanation of what the evidence allegedly shows.
`
`2054
`
`FRE 401/402: This document is irrelevant. Patent Owner
`
`has failed to identify any fact of consequence in determining
`
`an issue in this proceeding that is made more or less
`
`probable by this exhibit.
`
`FRE 403: Any probative value of the exhibit is substantially
`
`outweighed by a danger of confusing the issues.
`
`FRE 801/802: The exhibit relies on hearsay if offered to
`
`prove the truth of any matter allegedly asserted therein, and
`
`does not fall under any exceptions.
`
`FRE 901/902: Patent Owner has not produced evidence
`
`sufficient to support a finding that the exhibit is what Patent
`
`Owner claims it is. Nor has Patent Owner presented any
`
`evidence that the exhibit is self-authenticating under FRE
`
`902.
`
`
`
`10
`
`
`
`Petitioner Pfizer’s Objections to Admissibility of Evidence for IPR2017-01489
`
`Exhibit(s)
`
`Objections2
`FRE 1002/1003: Patent Owner has not shown this exhibit is
`
`the original document or an authentic duplicate.
`
`Lack of Foundation: Patent Owner has not provided
`
`sufficient explanation of what the evidence allegedly shows.
`
`2055
`
`FRE 401/402: This document is irrelevant. Patent Owner
`
`has failed to identify any fact of consequence in determining
`
`an issue in this proceeding that is made more or less
`
`probable by this exhibit.
`
`FRE 403: Any probative value of the exhibit is substantially
`
`outweighed by a danger of confusing the issues.
`
`FRE 801/802: The exhibit relies on hearsay if offered to
`
`prove the truth of any matter allegedly asserted therein, and
`
`does not fall under any exceptions.
`
`FRE 901/902: Patent Owner has not produced evidence
`
`sufficient to support a finding that the exhibit is what Patent
`
`Owner claims it is. Nor has Patent Owner presented any
`
`evidence that the exhibit is self-authenticating under FRE
`
`902.
`
`
`
`11
`
`
`
`Petitioner Pfizer’s Objections to Admissibility of Evidence for IPR2017-01489
`
`Exhibit(s)
`
`Objections2
`FRE 1002/1003: Patent Owner has not shown this exhibit is
`
`the original document or an authentic duplicate.
`
`Lack of Foundation: Patent Owner has not provided
`
`sufficient explanation of what the evidence allegedly shows.
`
`2056
`
`FRE 401/402: This document is irrelevant. Patent Owner
`
`has failed to identify any fact of consequence in determining
`
`an issue in this proceeding that is made more or less
`
`probable by this exhibit.
`
`FRE 403: Any probative value of the exhibit is substantially
`
`outweighed by a danger of confusing the issues.
`
`2057
`
`FRE 401/402: This document is irrelevant. Patent Owner
`
`has failed to identify any fact of consequence in determining
`
`an issue in this proceeding that is made more or less
`
`probable by this exhibit.
`
`FRE 403: Any probative value of the exhibit is substantially
`
`outweighed by a danger of confusing the issues.
`
`FRE 801/802: The exhibit relies on hearsay if offered to
`
`prove the truth of any matter allegedly asserted therein, and
`
`does not fall under any exceptions.
`
`
`
`12
`
`
`
`Petitioner Pfizer’s Objections to Admissibility of Evidence for IPR2017-01489
`
`Exhibit(s)
`
`Objections2
`FRE 901/902: Patent Owner has not produced evidence
`
`sufficient to support a finding that the exhibit is what Patent
`
`Owner claims it is. Nor has Patent Owner presented any
`
`evidence that the exhibit is self-authenticating under FRE
`
`902.
`
`FRE 1002/1003: Patent Owner has not shown this exhibit is
`
`the original document or an authentic duplicate.
`
`Lack of Foundation: Patent Owner has not provided
`
`sufficient explanation of what the evidence allegedly shows.
`
`2058
`
`FRE 401/402: This document is irrelevant. Patent Owner
`
`has failed to identify any fact of consequence in determining
`
`an issue in this proceeding that is made more or less
`
`probable by this exhibit.
`
`FRE 403: Any probative value of the exhibit is substantially
`
`outweighed by a danger of confusing the issues.
`
`FRE 801/802: The exhibit relies on hearsay if offered to
`
`prove the truth of any matter allegedly asserted therein, and
`
`does not fall under any exceptions.
`
`
`
`13
`
`
`
`Petitioner Pfizer’s Objections to Admissibility of Evidence for IPR2017-01489
`
`Exhibit(s)
`
`Objections2
`FRE 901/902: Patent Owner has not produced evidence
`
`sufficient to support a finding that the exhibit is what Patent
`
`Owner claims it is. Nor has Patent Owner presented any
`
`evidence that the exhibit is self-authenticating under FRE
`
`902.
`
`FRE 1002/1003: Patent Owner has not shown this exhibit is
`
`the original document or an authentic duplicate.
`
`Lack of Foundation: Patent Owner has not provided
`
`sufficient explanation of what the evidence allegedly shows.
`
`
`
`14
`
`
`
`
`
`
`
`Petitioner Pfizer’s Objections to Admissibility of Evidence for IPR2017-01489
`
`Date: March 15, 2018
`
`Respectfully submitted,
`
`
`
`
`
`
`
`
` /Amanda Hollis/
`Amanda Hollis (Reg. No. 55,629)
`KIRKLAND & ELLIS LLP
`300 North LaSalle Street
`Chicago, Illinois 60654
`P: 312.862.2000; F: 312.862.2200
`amanda.hollis@kirkland.com
`
`Attorney For Petitioner
`
`
`15
`
`
`
`Petitioner Pfizer’s Objections to Admissibility of Evidence for IPR2017-01489
`
`CERTIFICATE OF SERVICE
`The undersigned hereby certifies that a copy of the foregoing Objections was
`
`served on March 15, 2018, via electronic service on lead and back up counsel:
`
`ddrivas@whitecase.com
`sweingaertner@whitecase.com
`David.Cavanaugh@wilmerhale.com
`owen.allen@wilmerhale.com
`Robert.Gunther@wilmerhale.com
`ddurie@durietangri.com
`Lisa.Pirozzolo@wilmerhale.com
`Andrew.Danford@wilmerhale.com
`rebecca.whitfield@wilmerhale.com
`Kevin.Prussia@wilmerhale.com
`abrausa@durietangri.com
`
` /Amanda Hollis/
`Amanda Hollis
`
`
`
`
`
`
`16
`
`